The Genetic Architecture of SLD: Pioneering New Frontiers in Advanced Liver Disease

Description

This panel will explore the genetic architecture of steatotic liver disease (SLD) and its impact on managing advanced liver disease. Experts will discuss unmet needs, key genetic drivers, like HSD17B13, how factors like alcohol and diet influence disease progression and how genetics can shape the future therapeutic strategies for SLD.
Industry Supporter: GSK